This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

. 1983;25(4):569-70.

doi: 10.1007/BF00542131.

Variability of plasma drug concentrations: some observations

D B Jack, M R Wilkins, M J Kendall, P E Hall

PMID: 6653653
DOI: 10.1007/BF00542131

Variability of plasma drug concentrations: some observations

D B Jack et al. Eur J Clin Pharmacol. 1983.

. 1983;25(4):569-70.

doi: 10.1007/BF00542131.

Authors

D B Jack, M R Wilkins, M J Kendall, P E Hall

PMID: 6653653
DOI: 10.1007/BF00542131

No abstract available

PubMed Disclaimer

Similar articles

Design and evaluation of a drug analysis request/report form for therapeutic drug monitoring.
Lesko LJ. Lesko LJ. Drug Intell Clin Pharm. 1982 Oct;16(10):782-4. doi: 10.1177/106002808201601022. Drug Intell Clin Pharm. 1982. PMID: 7140518 No abstract available.
Clinical role of blood levels.
Latini R, Bonati M, Tognoni G. Latini R, et al. Ther Drug Monit. 1980;2(1):3-9. doi: 10.1097/00007691-198001000-00002. Ther Drug Monit. 1980. PMID: 6762702 Review. No abstract available.
Comment on therapeutic monitoring.
Buchanan C, Kaka JS. Buchanan C, et al. Drug Intell Clin Pharm. 1982 Jul-Aug;16(7-8):621-2. doi: 10.1177/106002808201600721. Drug Intell Clin Pharm. 1982. PMID: 7105985 No abstract available.
Progress in therapeutic drug monitoring: clinical laboratory considerations.
Jatlow P. Jatlow P. Prog Clin Pathol. 1981;8:153-73. Prog Clin Pathol. 1981. PMID: 7029623 Review. No abstract available.
Present and future trends in drug monitoring.
Tillement JP, Albengres E, Riani P, Bree F. Tillement JP, et al. Int J Clin Pharmacol Ther Toxicol. 1985 Apr;23 Suppl 1:S68-73. Int J Clin Pharmacol Ther Toxicol. 1985. PMID: 3842693

See all similar articles

Cited by

Implications of intraindividual variability in bioavailability studies of furosemide.
Grahnén A, Hammarlund M, Lundqvist T. Grahnén A, et al. Eur J Clin Pharmacol. 1984;27(5):595-602. doi: 10.1007/BF00556898. Eur J Clin Pharmacol. 1984. PMID: 6519165 Clinical Trial.
The polymorphic oxidation of beta-adrenoceptor antagonists. Clinical pharmacokinetic considerations.
Lennard MS, Tucker GT, Woods HF. Lennard MS, et al. Clin Pharmacokinet. 1986 Jan-Feb;11(1):1-17. doi: 10.2165/00003088-198611010-00001. Clin Pharmacokinet. 1986. PMID: 2868819 Review.
Variability of plasma drug concentrations--a reply.
Lennard MS, Jackson PR, Ramsay LE, Tucker GT, Woods HF. Lennard MS, et al. Eur J Clin Pharmacol. 1984;26(5):659. doi: 10.1007/BF00543508. Eur J Clin Pharmacol. 1984. PMID: 6468489 No abstract available.

References

1. Eur J Clin Pharmacol. 1982;23(1):37-42 - PubMed
1. Br J Clin Pharmacol. 1983 Aug;16(2):188-90 - PubMed
1. N Engl J Med. 1982 Dec 16;307(25):1558-60 - PubMed
1. Lancet. 1983 Jun 18;1(8338):1388 - PubMed
1. Br Med J (Clin Res Ed). 1983 Jun 18;286(6382):1978-9 - PubMed

MeSH terms

Actions
Actions
Actions

Substances

Actions

LinkOut - more resources

Full Text Sources
- Springer
Medical
- MedlinePlus Health Information